DrugPatentWatch Database Preview
Secura Company Profile
What is the competitive landscape for SECURA, and when can generic versions of SECURA drugs launch?
SECURA has one approved drug.
There are five US patents protecting SECURA drugs.
There are one hundred and five patent family members on SECURA drugs in forty-seven countries and fourteen supplementary protection certificates in twelve countries.
Summary for Secura
| International Patents: | 105 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Secura
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | RX | Yes | No | 7,067,551 | Start Trial | Start Trial | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | RX | Yes | No | 6,552,065 | Start Trial | Y | Y | Start Trial | ||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | RX | Yes | No | 8,883,842 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Secura Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2006278718 | Start Trial |
| Taiwan | I286544 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0222577 | Start Trial |
| Ecuador | SP088976 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Secura Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1318980 | 72/2015 | Austria | Start Trial | PRODUCT NAME: PANOBINOSTAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1023 (MITTEILUNG) 20150901 |
| 1318980 | CR 2015 00068 | Denmark | Start Trial | PRODUCT NAME: PANOBINOSTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER PANOBINOSTATLAKTAT; REG. NO/DATE: EU/1/15/1023 20150901 |
| 1912640 | PA2016003,C1912640 | Lithuania | Start Trial | PRODUCT NAME: PANOBINOSTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/15/1023 20120828 |
| 1318980 | 1590070-7 | Sweden | Start Trial | PRODUCT NAME: PANOBINOSTAT OR A PHARMACEUTICALLY ACCEPTABLE SALTTHEREOF; REG. NO/DATE: EU/1/15/1023 20150901 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
